XTX Topco’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $307K | Buy |
264,829
+140,433
| +113% | +$163K | 0.01% | 1413 |
|
2025
Q1 | $198K | Buy |
124,396
+1,408
| +1% | +$2.24K | 0.01% | 1708 |
|
2024
Q4 | $373K | Sell |
122,988
-71,074
| -37% | -$215K | 0.03% | 1020 |
|
2024
Q3 | $714K | Buy |
194,062
+15,597
| +9% | +$57.4K | 0.05% | 588 |
|
2024
Q2 | $730K | Buy |
178,465
+167,854
| +1,582% | +$687K | 0.06% | 484 |
|
2024
Q1 | $167K | Buy |
+10,611
| New | +$167K | 0.02% | 1230 |
|
2023
Q4 | – | Sell |
-19,008
| Closed | -$381K | – | 2235 |
|
2023
Q3 | $381K | Buy |
+19,008
| New | +$381K | 0.07% | 571 |
|
2023
Q2 | – | Sell |
-21,215
| Closed | -$365K | – | 1911 |
|
2023
Q1 | $365K | Buy |
+21,215
| New | +$365K | 0.08% | 498 |
|
2022
Q4 | – | Sell |
-9,655
| Closed | -$209K | – | 1567 |
|
2022
Q3 | $209K | Buy |
+9,655
| New | +$209K | 0.05% | 753 |
|